Dr. Hargobind Khurana: Genetic Code

-

 Hargobind Khurana was a scientist of Indian origin who made substantial discoveries in genetics and molecular biology. He was born on January 9, 1922, in Raipur, Punjab, British India (now Pakistan), and died on November 9, 2011, in Concord, Massachusetts.

Khorana is well known for his seminal work on the interpretation of the genetic code and nucleic acid synthesis, for which he received the Nobel Prize in Physiology or Medicine in 1968. Khorana shared the Nobel Prize with Robert W. Holley and Marshall W. Nirenberg for their discovery of how the arrangement of nucleotides in nucleic acids regulates protein production in cells. This research helped us grasp how DNA encodes genetic information and how it is translated into proteins.




During his work, Khorana achieved substantial advances in DNA chemistry, RNA synthesis, and genetic code decoding. He was instrumental in the creation of the first artificial gene and contributed to our understanding of how cells process genetic information.

Hargobind Khorana's seminal work in molecular biology and genetics opened up new fields of exploration. His efforts continue to have an impact on the profession, paving the door for several future discoveries and advances in genetic engineering and biotechnology.

Comments

Post a Comment

Popular posts from this blog

War of the Currents: The Rivality between Edison Vs Tesla

-
Image
 The "War of the Currents" was a time in history in the late nineteenth century when there was fierce competition between two competing electrical power systems: Thomas Edison's direct current (DC) system and Nikola Tesla and George Westinghouse's alternating current (AC) system. Thomas Edison pioneered the use of direct current (DC) electricity for electrical distribution through his firm Edison Electric Light firm (later known as General Electric or GE). Due to its restricted transmission capabilities, DC electricity travels in just one way and necessitates power plants being situated near customers. On the other side, Nikola Tesla, with the financial backing of George Westinghouse, lobbied for alternating current power. AC electricity allows for more efficient long-distance transmission and the use of transformers to step up or step down voltage levels as needed. As each side sought to control the burgeoning electric power business, tensions between these two syste
Read more

Henry Bragg & Lawrence Bragg : The Only Father Son duo who won the Noble Prize in Physics

-
Image
  Sir William Henry Bragg (1862-1942)       Born at Wigton, Cumberland, England, on July 2, 1862.    Studied  At King's College, Cambridge, he studied mathematics and physics.     Pioneered research in the field of X-ray crystallography.     Developed the concept of X-ray diffraction with his son Lawrence Bragg.     Proposed Bragg's law, which explains X-ray diffraction by crystals and allows crystal shapes to be determined.     The structure of numerous crystals, including minerals and chemical molecules, was investigated.     X-ray crystallography was used to investigate the molecular structures of key compounds such as proteins.     He was a professor at the Universities of Leeds (1909-1915) and Manchester (1915-1919).     In 1915, he and his son Lawrence shared the Nobel Prize in Physics for their work on X-ray crystallography.
Read more

Big Pharma Conspiracy

-
Image
 The term "Big Pharma conspiracy" refers to the widespread idea that pharmaceutical firms engage in clandestine and immoral practices in order to maximize profits at the expense of public health. While it is true that the pharmaceutical business is profit-driven, valid concerns regarding corporate practices must be distinguished from unsubstantiated conspiracy theories. Consider the following crucial points:     Research & Development: Creating new pharmaceuticals is a time-consuming and expensive process that requires considerable research, clinical trials, and regulatory clearance. Pharmaceutical businesses devote enormous amounts to research and development (R&D) in order to identify and commercialize new medications. While profit is a motivator, it is also vital to recuperate the significant expenditures of R&D and to support future innovation. Patent protection is obtained by pharmaceutical corporations in order to preserve their investments in medication d
Read more